62
Participants
Start Date
December 31, 2011
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
placebo
Administered for up to 8 weeks.
extended-release guanfacine
1 mg tablets; flexible dosing up to 4 mg/day for up to 16 weeks
Emory University, Atlanta
University of California, Los Angeles, Los Angeles
Seattle Children's Hospital, Seattle
Yale University, New Haven
Massachusetts General Hospital, Lexington
Emory University
OTHER
Massachusetts General Hospital
OTHER
Seattle Children's Hospital
OTHER
University of California, Los Angeles
OTHER
National Institute of Mental Health (NIMH)
NIH
Yale University
OTHER